3 results match your criteria: "Louis B. Stokes Veterans Affairs Medical Research Center[Affiliation]"

Parkinson's disease (PD) is the second most common neurodegenerative disease worldwide, caused by the degeneration of the dopaminergic neurons in the substantia nigra. Mutations in PARK7 (DJ-1) result in early onset autosomal recessive PD, and oxidative modification of DJ-1 has been reported to regulate the protective activity of DJ-1 in vitro. Glutathionylation is a prevalent redox modification of proteins resulting from the disulfide adduction of the glutathione moiety to a reactive cysteine-SH, and glutathionylation of specific proteins has been implicated in regulation of cell viability.

View Article and Find Full Text PDF

The roles of redox enzymes in Parkinson's disease: Focus on glutaredoxin.

Ther Targets Neurol Dis

January 2015

Department of Pharmacology, Case Western Reserve University, Cleveland, OH 44106, USA ; Louis B. Stokes Veterans Affairs Medical Research Center, Cleveland, OH 44106, USA.

Parkinson's disease (PD) results from the loss of dopaminergic neurons in the portion of the midbrain, and represents the second most common neurodegenerative disease in the world. Although the etiology of PD is currently unclear, oxidative stress and redox dysfunction are generally understood to play key roles in PD pathogenesis and progression. Aging and environmental factors predispose cells to adverse effects of redox changes.

View Article and Find Full Text PDF

Parkinson's disease (PD) is characterized by selective degeneration of dopaminergic neurons. Although the etiology of PD remains incompletely understood, oxidative stress has been implicated as an important contributor in the development of PD. Oxidative stress can lead to oxidation and functional perturbation of proteins critical to neuronal survival.

View Article and Find Full Text PDF